Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues. But according to a recent study, those benefits fade within two years of patients stopping their treatment.
According to a study published in the BMJ, data from 9,341 obese or overweight patients treated in 37 studies with any of 18 different weight-loss drugs showed that they regained about one pound on average after stopping the drugs.
The same study said they were projected to return to their pre-treatment weight in about two years.
But weight was not the only thing that was projected to return after stopping the treatment. According to the same study, health risk factors like blood pressure and cholesterol levels, which saw benefits while taking the drugs, were projected to return to their old levels within 1.4 years.
GLP-1 medications tested as well
About half of the patients studied took newer GLP-1 drugs like semaglutide, sold as Ozempic and Wegovy, as well as tirzepatide, which is sold as Mounjaro and Zepbound. According to the study, the weight regain rate was faster for these drugs, with an average of 1.8 pounds per month.
“But because people on semaglutide or tirzepatide lose more weight in the first place, they all end up returning to baseline at approximately the same time,” study senior researcher Dimitrios Koutoukidis of Oxford University told Reuters.
Weight loss drugs have shown some success
Weight loss drugs like the ones tested in the study have shown large levels of success in the United States in recent years. Back in October 2025, a survey from the Gallup National Health and Well-Being Index showed that there were an estimated 7.6 million fewer obese people in the United States compared to 2022.
In 2022, the U.S. adult obesity rate was a record-high 39.9%, while in 2025, that rate gradually declined to 37%. While the obesity rate dropped, the usage of GLP-1 drugs like Ozempic and Wegovy doubled between 2025 and 2024, according to the same study.
Contributing: Nicole Fallert, USA TODAY; Reuters
Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at [email protected] and follow him on X @fern_cerv_.
This article originally appeared on USA TODAY: Here's how fast you can gain weight after ending GLP-1, per study
LATEST POSTS
- 1
The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites - 2How to watch NASA's Artemis 2 astronauts launch to the moon on April 1
- 3Trump administration plan to reduce access to some student loans angers nurses, health care groups
- 4Becoming amazing at Systems administration: Individual and Expert Tips
- 5Wisconsin judge sends Slender Man attacker back to mental health institution after group home escape
- Pick Your Favored method of transportation
- IDF destroys regime's missile, sea mine production site in Yazd amid nationwide airstrikes
- The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby
- World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- At least 7 dead as Israel renews attacks on Beirut and across Lebanon
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- The Best 15 Applications for Efficiency and Association
- Instructions to Expand Your Advantages from an Open Record Reward
- 'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream'
